PharmacyCodes



Sodium myristyl sulfate en es it fr

Sodium myristyl sulfate Brand names, Sodium myristyl sulfate Analogs

Sodium myristyl sulfate Brand Names Mixture

  • No information avaliable

Sodium myristyl sulfate Chemical_Formula

C14H30O4S

Sodium myristyl sulfate RX_link

http://www.rxlist.com/cgi/generic2/sotradecol.htm

Sodium myristyl sulfate fda sheet

Sodium myristyl sulfate msds (material safety sheet)

Sodium_myristyl_sulfate MSDS

Sodium myristyl sulfate Synthesis Reference

No information avaliable

Sodium myristyl sulfate Molecular Weight

294.452 g/mol

Sodium myristyl sulfate Melting Point

No information avaliable

Sodium myristyl sulfate H2O Solubility

No information avaliable

Sodium myristyl sulfate State

Solid

Sodium myristyl sulfate LogP

No information avaliable

Sodium myristyl sulfate Dosage Forms

Solution for intramuscular injection

Sodium myristyl sulfate Indication

For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.

Sodium myristyl sulfate Pharmacology

Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.

Sodium myristyl sulfate Absorption

No information avaliable

Sodium myristyl sulfate side effects and Toxicity

LD50=1250 mg/kg (Orally in rat); LD50=3 ml/kg (Skin in rat)

Sodium myristyl sulfate Patient Information

No information avaliable

Sodium myristyl sulfate Organisms Affected

Humans and other mammals